Project Grant R01HL172813

Award Date 7/9/24
Completion Date 4/30/28
Dollars Obligated $2M
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Lexington, KY 40506, USA
Similar Awards
This Project Grant award of $721,041 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research to investigate the role of cardiac circadian clock misalignment in promoting ventricular arrhythmias and sudden cardiac arrest. The research will use a combination of donor human hearts and a swine model of chronic ischemia to determine if a diurnal window of arrhythmia vulnerability exists, examine the extent of cardiac circadian...
The National Heart, Lung, and Blood Institute awarded a $691,124 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Michigan. The grant supports research to investigate the longitudinal relationship between circadian disruption and cardiometabolic risk during the transition from adolescence to young adulthood. Key objectives include testing the hypothesis that persistent circadian disruption is related to the development of...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $143,829 to The University of Kentucky Research Foundation to establish human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a model for studying the circadian regulation of cardiomyocyte size and function. The 5-year award, beginning January 1, 2025, aims to: 1) determine how intrinsic cardiomyocyte circadian clocks impact cell size and...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) totaling $1,411,136 focuses on characterizing circadian rhythms in organ donors and identifying mechanisms by which donor and recipient circadian clocks affect transplant acceptance, with a focus on lung transplantation. The award aims to: 1) Generate an atlas of brain-dead organ donors' biological rhythms and circadian clock function, and develop a tool to infer circadian...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $524,390 to the University of Colorado-Denver to study the relationship between sleep health, circadian timing, and cardiometabolic risk in adolescents with type 1 diabetes. The research aims to utilize a combined sleep health and circadian timing intervention as a mechanistic probe to...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $451,250 in funding to the Children's Hospital Medical Center in Cincinnati, Ohio. The project aims to investigate the mechanisms that coordinate clock gene expression within the brain's central pacemaker and distributed brain oscillators, as well as how internal and external signals integrate to regulate circadian rhythms...
The National Heart, Lung, and Blood Institute (NHLBI) awarded The Trustees of Columbia University in the City of New York a $821,982 Project Grant under the Cardiovascular Diseases Research Federal Grant Program (CFDA 93.837). The grant, awarded on July 15, 2024, will fund a 5-year research project to investigate variability in sleep timing as a potential new risk factor for cardiovascular disease (CVD) among women. The study will leverage two racially and ethnically diverse cohorts of women...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) federal grant program, supports research to mechanistically understand how circadian and metabolic rhythms shape the maturation and maintenance of fully differentiated cells. The $406,250 award, effective June 12, 2025 through April 30, 2030, will enable the research team at the University of Pennsylvania to: 1) Determine how circadian...
This $684,116 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to examine the mechanisms by which improving sleep regularity affects glycemic control and cardiovascular disease (CVD) risk in adults with type 1 diabetes. The grant will fund a 4-week behavioral sleep stability intervention in 80 adults with type 1 diabetes and irregular sleep...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $386,900.00 to the University of Texas Health Science Center at Houston (UTHealth) to study the role of the circadian clock and retinoid acid receptor-related orphan receptor (ROR) proteins in regulating metabolic function and healthy aging. The key objectives are to: 1) Evaluate the impact of ROR proteins on healthspan and lifespan using mice with skeletal muscle-specific ROR knockout, 2)...

CIRCADIAN REGULATION OF CARDIAC ELECTROPHYSIOLOGY - ABSTRACT. CIRCADIAN CLOCKS PLAY A FUNDAMENTAL ROLE IN ALIGNING PHYSIOLOGICAL AND BEHAVIORAL PROCESSES TO PREDICTABLE CHANGES IN THE DAILY ENVIRONMENT. FOR DECADES, CIRCADIAN SIGNALING HAS BEEN IMPLICATED IN THE DEVELOPMENT OF CARDIAC ARRHYTHMIAS AND SUDDEN CARDIAC DEATH (SCD) IN INDIVIDUALS WITH CARDIOVASCULAR DISEASE. HOWEVER, NUMEROUS CRITICAL KNOWLEDGE GAPS PERSIST REGARDING THE CONNECTION BETWEEN CIRCADIAN CLOCKS, CIRCADIAN RHYTHMS, AND SCD. THIS RESEARCH PROPOSAL ADDRESSES THESE KNOWLEDGE GAPS BY INVESTIGATING THE MOLECULAR MECHANISMS UNDERLYING THE CIRCADIAN REGULATION OF ION CHANNEL TRANSCRIPTS AND PROTEINS THAT IMPACT ARRHYTHMIA SUSCEPTIBILITY. AIM 1 WILL ELUCIDATE THE MOLECULAR MECHANISMS RESPONSIBLE FOR THE CIRCADIAN REGULATION OF CARDIAC ION CHANNEL GENES ESSENTIAL FOR CARDIAC EXCITABILITY. THROUGH COMPREHENSIVE PROMOTER ANALYSES UTILIZING REAL-TIME BIOLUMINESCENCE ASSAYS (LUMICYCLE), WE WILL IDENTIFY THE CONSERVED CIS-REGULATORY ELEMENT(S) ESSENTIAL FOR CIRCADIAN ACTIVITY. THE IDENTIFIED CIS-REGULATORY ELEMENT(S) WILL BE VALIDATED USING CHROMATIN IMMUNOPRECIPITATION AND ELECTROPHORETIC MOBILITY SHIFT ASSAYS. AIM 2 FOCUSES ON DETERMINING HOW CIRCADIAN ALIGNMENT AND MISALIGNMENT AFFECT THE TRANSCRIPTION AND TRANSLATION OF GENES ESSENTIAL FOR NORMAL CARDIAC ELECTROPHYSIOLOGY. WE WILL EXPLORE THE IMPACT OF TIME-RESTRICTED FEEDING ON THE TRANSCRIPTIONAL AND TRANSLATIONAL REGULATION OF MYOCARDIAL GENES IMPORTANT FOR CARDIAC EXCITABILITY BY EMPLOYING MRNA-SEQ AND RIBO-SEQ TECHNOLOGY. AIM 3 WILL DETERMINE THE PHYSIOLOGICAL IMPLICATIONS OF CIRCADIAN ALIGNMENT AND MISALIGNMENT ON CARDIAC ELECTROPHYSIOLOGY, AUTONOMIC REGULATION, AND ARRHYTHMIA SUSCEPTIBILITY. WE WILL ASSESS THE IMPACT OF MANIPULATING FEEDING-FASTING CYCLES ON CARDIAC ELECTROPHYSIOLOGY AND ARRHYTHMIA SUSCEPTIBILITY UTILIZING AN ARRHYTHMOGENIC MOUSE MODEL WITH IMPAIRED CARDIAC CONDUCTION AND VENTRICULAR REFRACTORINESS (SCN5A+/-). WE WILL ALSO INVESTIGATE HOW FEEDING-FASTING CYCLES MODULATE THE AUTONOMIC NERVOUS SYSTEM'S REGULATION OF CARDIAC ELECTROPHYSIOLOGY USING AN INDUCIBLE CARDIOMYOCYTE-SPECIFIC RRAD KNOCKOUT MOUSE MODEL (ICSDRRAD). THIS INTERDISCIPLINARY PROJECT LIES AT THE INTERFACE BETWEEN CHRONOBIOLOGY AND CARDIAC ELECTROPHYSIOLOGY, AND IT WILL GENERATE NEW KNOWLEDGE TO PROVIDE VALUABLE INSIGHT INTO HOW CIRCADIAN CLOCKS AND ALIGNMENT IMPACT THE RISK FOR CARDIAC ARRHYTHMIAS. IN ADDITION, THE RESULTS OF THIS PROJECT ARE EXPECTED TO IDENTIFY NOVEL CHRONOTHERAPEUTIC STRATEGIES THAT CAN READILY BE ADOPTED TO MITIGATE ARRHYTHMOGENIC RISK IN VULNERABLE POPULATIONS.

Posted 7/9/24, 12:00 AM